Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.



Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.

Contact SupportLog In

news cover image
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Glucose Monitoring, Other Apr 29 | 2021Dexcom, Teladoc, Amarin, Biocon, and Merck Q1 '21 Earnings Updates; Abbott Libre 3 User ReviewsPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Glucose Monitoring, Other Apr 28 | 2021Welldoc Receives New Patent; Nemaura Shareholder Update; Sanofi and Teva Q1 '21 Earnings UpdatesPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA, SGLT2i Apr 19 | 2021April 19-22 CHMP Agenda; EMPEROR-REDUCED Opinion?; Virta Health Raises $133M in Series EPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Apr 19 | 2021Insulet Omnipod 5 Tale-of-the-tape AnalysisPurchase Blast
$599
Posted in: Glucose Monitoring Apr 05 | 2021Dexcom and Welldoc Expand Partnership for T2DMPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Mar 29 | 2021New Medtronic/InPen MDI Basal+Bolus Advisement Connected SystemPurchase Blast
1 44 45 46 47 48 99